OnePlus' affordable smartphone brand 'Nord' to arrive first in India
by Maria Thomas | Updated Jun 30, 2020
Earlier speculations suggested that the affordable OnePlus smartphone could be called OnePlus Z or OnePlus 8 Lite.
OnePlus said that the Nord product line follows the company's new global business strategy, which includes introducing new products at more affordable price segments.
The new product line also addresses feedback from OnePlus' growing community of users, who have shown a strong desire for a more affordable smartphone that incorporates OnePlus' flagship-level product and user experience standards.
"Launching the OnePlus Nord product line marks the beginning of an exciting new chapter for OnePlus. The ‘Never Settle' spirit is centered around sharing the best technology and products with the world, but it is also about challenging ourselves and going beyond our comfort zone," Pete Lau, Founder and CEO of OnePlus, said in a statement.
"We are immensely proud of our flagship products and will continue to create more tech-leading flagships for our users. Now we are excited to share the OnePlus experience with even more users around the world through this new product line."
A select number of users in North America will also get a chance to experience the new device through a highly limited beta program after launch, OnePlus said.
In India, users can log on to Amazon.in and click on the Notify Me button to stay updated on OnePlus Nord.
Related Articles
- Optical Illusion Brain Test: If you have Sharp Eyes Find the Number 442 in 20 Secs
- London-based firm Nothing to release its Phone (2)
- Covid will continue to cause mini-waves, not become seasonal yet: Scientists
- Hackers offering crypto accounts for as low as $30 on darknet
- Reddit's new feature to allow users to share its content on other platforms
- Surgical masks can help kids fight respiratory infections: Study
- LinkedIn's new AI feature to write messages to hiring team
- Microsoft introduces Xbox Game Pass' new Friend Referral programme
- Disbursed over Rs 31 cr in claims to delivery partners in FY22-23: Swiggy
- India emerging as favourable destination for clinical trials: Report